Dermata Therapeutics, Inc. (DRMA)
$1.63+14.79%Close
BUYRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $1M
- Avg volume
- 73.5K
- Beta
- 0.66
- P/E (TTM)
- -0.36
- Short % float
- 10.18%
- Days to cover
- 1.0
- SI change
- -21.7%
- 1W
- +11.64%
- 1M
- +23.48%
- 3M
- +29.37%
- YTD
- -25.23%
- vs SPY 1W
- +12.83%
- vs SPY 1M
- +20.16%
- vs SPY 3M
- +26.97%
- vs SPY YTD
- -36.98%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- ACTUBUYActuate Therapeutics IncRECOVERYQ -27$1.23-3.15%
- LUNGBUYPulmonx CorporationRECOVERYQ -24$2.28+0.88%
- QTIBUYQT Imaging Holdings, Inc.RECOVERYQ 34$3.31+13.75%
- SRTSBUYSensus Healthcare, Inc.RECOVERYQ -2$3.49+4.49%
- LIMNSELLLiminatus Pharma, Inc. Class A Common StockCRISISQ -26$4.67-9.50%
- HOOKSELLHOOKIPA Pharma Inc.BULLQ -18$1.15+0.00%
- NVAXBUYNovavax, Inc.RECOVERYQ 9$8.86-0.89%
- ORGOSELLOrganogenesis Holdings Inc.CRISISQ 5$1.67-7.22%
- XFORBUYX4 Pharmaceuticals, Inc.RECOVERYQ -12$4.05+0.25%
- WHWKBUYWhitehawk Therapeutics IncRECOVERYQ -12$4.88+3.17%
- DMRABUYGalecto, Inc.RECOVERYQ -3$30.31-1.65%
- PHIOBUYPhio Pharmaceuticals Corp.RECOVERYQ 3$1.17-0.85%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 8
- VALUE
- 13
- GROWTH
- 39
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-100.0%
REV YoY-
ROE-166.7%
EPS YoY-
ROA-157.3%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.36
P/E FWD-
SECTOR PE22.62
INDUSTRY PE17.13
P/B1.80
P/FCF-
EV/EBITDA0.39
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO2.81
ND/EBITDA-
BETA0.66
